Selected article for: "report case and risk population"
Author: EL aidouni, Ghizlane; Merbouh, Manal; Aabdi, Mohammed; Bouabdallaoui, Amine; Bkiyar, Houssam; Smaili, Nabila; Elouafi, Nouha; Housni, Brahim
Title: Intra cardiac thrombus in critically ill patient with coronavirus disease 2019: Case report
  • Cord-id: jd9j1o3d
  • Document date: 2021_5_26
    • ID: jd9j1o3d
    Snippet: INTRODUCTION: With the outbreak of COVID-19, the number of cardiac manifestations related to this virus was more remarquable, among them heart thrombus (HTh) which is considered as a rare and severe complication associated with thromboembolic phenomena. METHODS: We present case report of 4 patients who presented heart thrombus as a complication of COVID-19. CASES REPORT MANAGEMENT: During the pandemic, these patients were presented to our center for respiratory symptoms related to COVID-19 infec
    Document: INTRODUCTION: With the outbreak of COVID-19, the number of cardiac manifestations related to this virus was more remarquable, among them heart thrombus (HTh) which is considered as a rare and severe complication associated with thromboembolic phenomena. METHODS: We present case report of 4 patients who presented heart thrombus as a complication of COVID-19. CASES REPORT MANAGEMENT: During the pandemic, these patients were presented to our center for respiratory symptoms related to COVID-19 infection. All of them was hemodynamically unstable. On further assessment, Diagnosis was confirmed by trans -thoracic echography, one patient (1/4) had left ventricle thrombus, one patient (1/4) had right atrium thrombus and right ventricle thrombus was dominated in the rest of patients (2/4). Therapeutic component was based on unfractionated heparin and fibrinolytic. CONCLUSION: COVID-19 patients could represent a population at high risk of HTh. Multidisciplinary approach and bed routine transthoracic echography can enhance the management of this cardiac complication.

    Search related documents:
    Co phrase search for related documents
    • acute lymphopenia and lung damage: 1, 2
    • acute lymphopenia and lung disease: 1
    • acute renal failure and adequate treatment: 1, 2
    • acute renal failure and admission day: 1, 2, 3, 4, 5, 6
    • acute renal failure and lung damage: 1, 2
    • acute renal failure and lung disease: 1, 2, 3, 4
    • acute respiratory syndrome and adequate treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and admission day: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low blood pressure: 1, 2, 3, 4
    • acute respiratory syndrome and lung damage: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung disease infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • adequate treatment and admission day: 1, 2
    • adequate treatment and lung damage: 1
    • adequate treatment and lung disease: 1, 2, 3, 4, 5
    • admission day and lung damage: 1, 2, 3, 4
    • admission day and lung disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12